REG - GlaxoSmithKline PLC - Publication of full year 2021 results

GSKAnnouncement

07/02/2022 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220207:nRSG8776Aa&default-theme=true

RNS Number : 8776A  GlaxoSmithKline PLC  07 February 2022

 

GlaxoSmithKline plc

 

Publication of full year 2021 results

 

 

GlaxoSmithKline plc will announce its full year and fourth quarter 2021
results to the London Stock Exchange at 07:00 GMT on Wednesday 9 February
2021.

 

Analysts and investors are invited to participate in a conference call and
webcast, including a presentation of the results and a Q&A session. This
event will take place on the same day at 14:00 GMT.

 

To participate, please join the live audio webcast, which can be accessed
directly via the website
(https://www.gsk.com/en-gb/investors/quarterly-results/) . The
presentation will also be available on the website
(http://www.gsk.com/en-gb/investors/quarterly-results/)  about one hour
before the event's start.

 

 

V A Whyte

Company Secretary

 

7 February 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORGCGDDUUGDGDR